/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-03-01 16:16:582024-10-10 08:32:23Efficacy and safety of arimoclomol in Niemann-Pick disease type C: Results from a double-blind, randomised, placebo-controlled, multinational phase 2/3 trial of a novel treatment
/wp-content/uploads/logo.svg
0
0
eallison
/wp-content/uploads/logo.svg
eallison2023-02-23 17:10:152024-10-10 08:37:21Association Between NPC Severity Score Domains and Corresponding Items of the Performance-based Scale for the Assessment and Rating of Ataxia (SARA)
/wp-content/uploads/logo.svg
0
0
eallison
/wp-content/uploads/logo.svg
eallison2023-02-23 17:01:492024-10-10 08:37:21Evaluation of the Long-Term Effect of Arimoclomol in NPC
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-01-26 11:08:202024-10-10 08:40:45Pharmacokinetics and Abuse Potential of Benzhydrocodone, A Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-01-26 11:07:392024-10-10 08:40:45Oral pharmacokinetics of KP511, a prodrug of hydromorphone, relative to hydromorphone in human volunteers
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-01-26 11:03:532024-10-10 08:40:45Pharmacokinetics and Abuse Potential of KP511, a Novel Prodrug of Hydromorphone, after Intranasal Administration in Recreation Drug Users
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-01-26 11:01:492024-10-10 08:40:45Single- and Multiple-dose Pharmacokinetics of KP415, a Novel d-Methylphenidate Product Containing a Prodrug of d-Methylphenidate, in Healthy Volunteers
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-01-26 10:59:342024-10-10 08:39:35Dose-finding Study of Abuse-Related Effects of Intranasal d-Methylphenidate in Recreational Stimulant Abusers
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-01-26 10:58:532024-10-10 08:39:35Human Abuse Potential of Intravenous Serdexmethylphenidate (SDX), a Novel Prodrug of d-Methylphenidate, in Recreational Stimulant Abusers
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-01-26 10:55:452024-10-10 08:39:35Assessment of the Intravenous Abuse Potential Of Serdexmethylphenidate (SDX), a Novel, Investigational Prodrug of D-Methylphenidate: Evidence from Nonclinical and Clinical Studies
Scroll to top
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settings
Cookie and Privacy Settings
